1999
DOI: 10.1002/1529-0131(199906)12:3<227::aid-art11>3.0.co;2-2
|View full text |Cite
|
Sign up to set email alerts
|

Mixed connective tissue disease, or should it be Sharp's syndrome? Comment on the article by Farhey and Hess

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2015
2015
2016
2016

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 7 publications
0
2
0
Order By: Relevance
“…6 Over the past 30 years there has been a continuing debate as to whether MCTD constitutes a "distinct clinical entity" and it still remains a controversial diagnosis. 7 Most authors agree that MCTD is a distinctive entity rather than a haphazard association of clinical and serological features and that the presence of high titres of autoantibodies to U1RNP influences the expression of connective tissue disease in ways that are relevant to prognosis and treatment. 8 In present patient, the clinical examination and the data obtained by investigations did not permit us to include this case in one of the typical, well established CTDs.…”
Section: Discussionmentioning
confidence: 99%
“…6 Over the past 30 years there has been a continuing debate as to whether MCTD constitutes a "distinct clinical entity" and it still remains a controversial diagnosis. 7 Most authors agree that MCTD is a distinctive entity rather than a haphazard association of clinical and serological features and that the presence of high titres of autoantibodies to U1RNP influences the expression of connective tissue disease in ways that are relevant to prognosis and treatment. 8 In present patient, the clinical examination and the data obtained by investigations did not permit us to include this case in one of the typical, well established CTDs.…”
Section: Discussionmentioning
confidence: 99%
“…5 The relevance of defining MCTD as a separate disease entity has been challenged, some authors considering it just a subset of SLE. 6 Over the past 30 years there has been a continuing debate as to whether MCTD constitutes a "distinct clinical entity" and it still remains a controversial diagnosis. 7 Most authors agree that MCTD is a distinctive entity rather than a haphazard association of clinical and serological features and that the presence of high titres of autoantibodies to U1RNP influences the expression of connective tissue disease in ways that are relevant to prognosis and treatment.…”
Section: Discussionmentioning
confidence: 99%